<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2010</study_start_year><condition>Neoplastic Cells, Circulating</condition><condition>Colorectal Cancer</condition><condition>Colorectal Neoplasms</condition><condition>Metastasis</condition><disease>Neoplastic Cells, Circulating</disease><disease>Colorectal Cancer</disease><disease>Colorectal Neoplasms</disease><disease>Metastasis</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2092151</full_dataset_link><location>Hong Kong</location><study_start_month>6</study_start_month><keyword>Identifying an early indicator of drug efficacy</keyword><repository>ECRIN MDR</repository><study_status>Completed</study_status></additional><is_claimable>false</is_claimable><name>PET-CT and Circulating Tumor Cells in Colorectal Cancer</name><description>The purpose of this study is to identify an early indicator of drug efficacy in patients with advanced colorectal cancer - a prospective evaluation of circulating tumor cells, positron-emission tomography scan and RECIST criteria.</description><dates><creation>2010-06-15</creation></dates><accession>2092151</accession><cross_references><ClinicalTrials___gov>NCT01163305</ClinicalTrials___gov></cross_references></HashMap>